| APGEApogee Therapeutics, Inc. | 1,920,800 | $161.7M |
| SYRESpyre Therapeutics, Inc. | 2,790,785 | $140.8M |
| DFTXDefinium Therapeutics Inc. | 5,911,889 | $111.7M |
| SRRKScholar Rock Holding Corp | 1,920,233 | $94.4M |
| BBIOBridgeBio Pharma, Inc. | 1,146,671 | $85.2M |
| GPCRStructure Therapeutics Inc. | 1,577,356 | $76.0M |
| PTGXProtagonist Therapeutics, Inc | 720,928 | $76.0M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 1,190,335 | $74.6M |
| PTCTPTC THERAPEUTICS, INC. | 1,015,772 | $69.2M |
| ARQTArcutis Biotherapeutics, Inc. | 2,226,029 | $52.4M |
| AXSMAxsome Therapeutics, Inc. | 292,370 | $49.4M |
| NUVLNuvalent, Inc. | 481,180 | $49.3M |
| ONCBeOne Medicines Ltd. | 155,002 | $46.0M |
| TVTXTravere Therapeutics, Inc. | 1,282,518 | $38.1M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 436,546 | $38.0M |
| KNSAKiniksa Pharmaceuticals International, plc | 611,398 | $29.4M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 317,312 | $26.6M |
| ADPTAdaptive Biotechnologies Corp | 1,750,601 | $24.3M |
| LGNDLigand Pharmaceuticals Incorporated | 118,169 | $23.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 59,622 | $19.7M |
| MAZEMaze Therapeutics, Inc. | 636,162 | $19.0M |
| DSGNDesign Therapeutics, Inc. | 1,744,987 | $18.6M |
| INSMINSMED Inc | 105,414 | $17.2M |
| RLMDRELMADA THERAPEUTICS, INC. | 2,132,053 | $14.8M |
| EXELEXELIXIS, INC. | 336,706 | $14.4M |
| ABCLAbCellera Biologics Inc. | 4,024,779 | $14.0M |
| LRMRLarimar Therapeutics, Inc. | 2,934,399 | $13.2M |
| INCYIncyte Corp. | 128,144 | $12.1M |
| ALXOALX ONCOLOGY HOLDINGS INC | 5,734,620 | $11.5M |
| KALVKalVista Pharmaceuticals, Inc. | 564,039 | $11.4M |
| IVVDInvivyd, Inc. | 8,436,894 | $11.0M |
| ANIPANI PHARMACEUTICALS INC | 121,459 | $9.3M |
| JBIOJade Biosciences, Inc. | 635,498 | $8.9M |
| XERSXeris Biopharma Holdings, Inc. | 902,740 | $5.2M |
| KRROKorro Bio, Inc. | 450,045 | $5.1M |
| CLYMClimb Bio, Inc. | 600,946 | $4.1M |
| SIONSionna Therapeutics, Inc. | 76,633 | $3.1M |
| PGENPRECIGEN, INC. | 793,773 | $3.1M |
| PTNPALATIN TECHNOLOGIES INC | 166,713 | $2.9M |
| NGNENeurogene Inc. | 32,765 | $661K |
| GILDGILEAD SCIENCES, INC. | 4,085 | $569K |